IMI - Clinical Myopia Control Trials and Instrumentation Report

Area of Science:

• Ophthalmology
• Optometry
• Clinical Research

Background:

• Myopia control trials aim to slow myopia progression and assess treatment effectiveness.
• Standardized outcome measures are crucial for evaluating myopia control interventions.
• Existing literature and trial data inform best practices in myopia management.

Purpose of the Study:

• To review and classify outcomes for myopia control clinical trials.
• To identify and critique instrumentation for measuring myopia progression.
• To provide recommendations for future trial design and instrumentation.

Main Methods:

• Systematic review of myopia control trial evidence and academic literature.
• Classification of outcomes into primary, secondary, and exploratory categories.
• Critique of current instrumentation for assessing myopia control efficacy.

Main Results:

• Primary outcomes include refractive error and axial length; secondary outcomes involve patient-reported data and compliance.
• Exploratory outcomes encompass a wide range of ocular measurements and patient factors.
• Current instrumentation is best suited for primary and secondary outcomes, with limitations noted.

Conclusions:

• Recommendations are provided for future myopia control trial protocols and instrumentation development.
• Standardized outcome selection and measurement are vital for advancing myopia control research.
• Addressing study design and patient selection issues will enhance trial validity.